Condition: Head and Neck Cancer · Sponsor: Turku University Hospital
This study is designed to evaluate the performance of advanced magnetic resonance (MR) imaging in the assessment of tumor hypoxia using \[18F\]EF5 positron emission tomography (PET) as a reference in head and neck cancer patients. Low oxygen level or hypoxia contributes to radiotherapy resistance. Therefore, a clinically applicable method to detect tumor hypoxia is of great importance.
This description comes directly from the study's public registry record.
Jussi Hirvonen, MD, PhD · 0035823130000 · jussi.hirvonen@tyks.fi
Antti Silvoniemi, MD, PhD · 0035823130000 · antti.silvoniemi@tyks.fi
Always discuss trial participation with your own doctor first.
| Turku University Hospital | Turku, G102881, Finland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05246475